Who Can Prescribe and Administer Botox and Fillers in the UK? A Clear Guide (2026)
Written by Dr Tom Fisher, GP and founder of Fisher Clinics. Last reviewed 03/08/2026.
This is one of the most misunderstood areas in aesthetics, for practitioners and patients alike. The confusion usually comes from mixing up two separate questions: who can prescribe a treatment, and who can administer it. They have different rules.
This guide gives you the quick answer first, then explains the detail underneath, so you can find what you need in seconds and read further if you want to understand why.
(This guide focuses on the position in England. Some rules differ in Scotland, Wales and Northern Ireland. Regulation in this area is also changing, so treat it as a current overview rather than the final word, and check the up-to-date position before relying on it.)
The quick answer
Botulinum toxin ("Botox") is a prescription-only medicine (POM). It must be prescribed, after a face-to-face assessment, by one of the following:
a doctor (GMC registered);
a dentist (GDC registered);
a nurse independent prescriber (holding the V300 qualification, NMC registered); or
a pharmacist independent prescriber (GPhC registered).
A nurse or pharmacist without an independent prescribing qualification cannot prescribe it.
Who can administer (inject) it? There is currently no law in England that restricts who may inject botulinum toxin, provided it has been lawfully prescribed for that specific, personally assessed patient. In practice it should always be given by someone appropriately trained, competent and insured.
Dermal fillers are different. Most dermal fillers are classed as medical devices, not prescription-only medicines, so they do not require a prescriber at all. Legally, anyone can inject them. This is precisely why fillers are considered one of the higher-risk areas and are a focus of incoming regulation.
Hyaluronidase (the enzyme used to dissolve hyaluronic-acid filler, including in emergencies) is a prescription-only medicine, so it also requires an authorised prescriber.
Remote prescribing is not allowed. Injectable cosmetic medicines must not be prescribed by phone, video or online. The prescriber must assess the patient face to face.
Who can prescribe botulinum toxin:
Doctors (GMC) - yes, within their competence.
Dentists (GDC) - yes as registrants, but see the scope note below.
Nurse independent prescribers holding the V300 (NMC) - yes, within their competence.
Pharmacist independent prescribers (GPhC) - yes, within their competence.
Supplementary prescribers - only within an agreed clinical management plan, with a doctor as the independent prescriber.
Who cannot prescribe (but may still administer a prescribed treatment):
Nurses without the V300 qualification.
Pharmacists without independent prescribing.
Beauticians, aestheticians and other non-prescribers.
Anyone in the second group may still, in law, administer toxin that has been properly prescribed for a specific patient, provided they are trained, competent and insured. They simply cannot prescribe it themselves.
There is one important age restriction. In England, it is illegal to administer botulinum toxin or dermal fillers for cosmetic purposes to anyone under 18, except where the treatment is provided for an approved medical reason by an appropriately qualified healthcare professional.
The two ideas that clear up most of the confusion
Almost every myth in this area dissolves once you separate two things.
1. Prescribing is not the same as administering.
Prescribing is the clinical decision that a specific patient should receive a specific medicine, made after assessing them. Administering is the act of injecting it. In UK aesthetics these can be done by two different people: an authorised prescriber assesses the patient and prescribes, and a trained injector (who may or may not be the prescriber) administers. The prescriber remains responsible for their prescribing decision.
2. Not every injectable is a prescription-only medicine.
Botulinum toxin is a POM, so it needs a prescriber. Hyaluronidase is a POM, so it needs a prescriber. But most dermal fillers are medical devices, not medicines, so legally they need no prescriber at all. That is why "who can inject filler" and "who can prescribe Botox" have such different answers, and why the filler market has historically been the least controlled.
Once you hold those two ideas in mind, the rest of this guide is simply the detail.
Prescribing in detail
Botulinum toxin is classified as a prescription-only medicine under the Human Medicines Regulations 2012. It can only be supplied and administered in accordance with a prescription from an authorised prescriber who has assessed the patient.
The authorised prescribers are doctors, dentists, nurse independent prescribers and pharmacist independent prescribers. Supplementary prescribers can prescribe only within an agreed clinical management plan alongside a doctor acting as the independent prescriber.
The prescriber must:
personally assess the patient, in person, before prescribing;
be satisfied the treatment is appropriate, safe and within their competence;
prescribe for a named individual, not for unnamed or future patients; and
take responsibility for that prescribing decision, including where someone else administers the treatment.
A note on dentists. Dentists are authorised prescribers and can prescribe botulinum toxin. However, as covered in our GDC guide, the GDC currently treats cosmetic botulinum toxin and filler treatments as activities outside the practice of dentistry. A dentist providing them is extending their personal scope of practice into a non-dental area and must be able to evidence the training, competence and indemnity to do so. Being an authorised prescriber and being within your professional scope of practice are two different tests, and both matter.
Administering in detail
Here is the point that surprises many people: there is currently no specific statutory restriction on who may administer non-surgical botulinum toxin in England. The law restricts prescribing, not injecting.
That means a non-prescriber, including in principle someone with no clinical registration, can lawfully administer botulinum toxin, provided:
it has been prescribed by an authorised prescriber;
the prescriber personally assessed that specific patient face to face; and
the person injecting is appropriately trained, competent and insured.
For dermal fillers, because they are usually medical devices rather than POMs, there is no prescription requirement at all, so there is even less legal control over who injects them.
This gap between "prescription-controlled" and "administration-uncontrolled" is widely regarded as a patient-safety weakness, and it is a major reason a new licensing scheme is being developed (covered in a separate guide).
The phrase “appropriately trained” is not precisely defined in law. In practice, practitioners should have appropriate, evidence-based training for the procedures they perform, maintain relevant CPD and indemnity, and be competent to recognise and manage complications.
The remote-prescribing ban
The professional standards applying to doctors, dentists, nurse prescribers and pharmacist prescribers prohibit the remote prescribing of injectable cosmetic medicines. The prescriber must assess the patient face to face before prescribing botulinum toxin or hyaluronidase for a non-surgical cosmetic procedure.
In practical terms, this means a prescriber must not prescribe botulinum toxin or hyaluronidase for a non-surgical cosmetic procedure:
by telephone, video link or online;
at the request of another person, for a patient they have not personally examined; or
in advance, for unnamed patients.
A proper face-to-face assessment of the individual patient by the prescriber is required. "Prescribe-and-go" arrangements, where a prescriber signs prescriptions for patients they have never seen, are not compliant and put the prescriber's registration at risk.
This is not a grey area, and it is being actively enforced. Regulators and the MHRA have pursued enforcement action against practitioners and pharmacists breaching these rules.
The PGD myth: why you usually cannot use one for cosmetic Botox
A common misunderstanding is that a Patient Group Direction (PGD) lets a non-prescriber give botulinum toxin without an individual prescription. In most aesthetic settings, this is wrong.
A PGD is a legal mechanism allowing specified healthcare professionals to supply and administer certain POMs without an individual prescription, and it is used widely in the NHS, for example for vaccinations. But there are two problems in aesthetics:
PGDs can generally only be used in CQC-registered providers (or settings with an appropriate NHS contractual arrangement). Most private aesthetic clinics are not CQC registered, so a PGD is not available to them.
The common cosmetic POMs are not well suited to PGDs. Guidance is clear that botulinum toxin should be given against an individual prescription or a patient specific direction (PSD) following personal assessment, not a PGD.
There are further practical problems worth knowing:
Many indemnity providers will not cover botulinum toxin administered under a PGD, only under an individual prescription.
The CQC has raised concerns about PGD use in aesthetics, particularly where the signing prescriber has little real involvement in the patient's care.
Many PGD templates circulating in the sector are generic and have not been properly authorised, so they do not meet the legal requirements in any case.
The safe and correct route in private aesthetic practice is an individual prescription (or a patient specific direction) following a face-to-face assessment by the prescriber, not a downloaded PGD.
Toxin, fillers and hyaluronidase: a quick comparison
Botulinum toxin (Botox, Azzalure, Bocouture and others): prescription-only medicine. Needs an authorised prescriber and a face-to-face assessment. Injecting is not separately restricted in law but should be done by a trained, insured practitioner.
Dermal fillers (most hyaluronic-acid fillers): medical devices, not POMs. No prescriber legally required, which is why this is the least controlled area and a focus of incoming regulation.
Hyaluronidase (used to dissolve hyaluronic-acid filler, and as the emergency treatment for suspected vascular occlusion): prescription-only medicine. Needs an authorised prescriber. This matters even for non-prescribing injectors, because if you inject filler, you need a plan for rapid access to hyaluronidase in an emergency. This is one of the strongest arguments for a genuine prescriber relationship rather than a distant "prescribe-and-go" arrangement.
What this means for you as a practitioner
If you are building or running an aesthetic practice, a few principles follow from all of the above:
Know your own status. If you are not an independent prescriber, you cannot prescribe, and you will need a genuine, compliant prescribing relationship with someone who is, based on real face-to-face assessment of each patient.
Avoid remote-prescribing and prescribe-and-go models. They are non-compliant and put registrations at risk.
Do not rely on a generic PGD for cosmetic botulinum toxin in a non-CQC-registered private clinic.
Make sure you can access hyaluronidase quickly if you inject filler, because vascular occlusion is a time-critical emergency.
Check your indemnity actually covers the exact treatments, products and prescribing arrangements you use.
Keep clear records. For every treatment, you should be able to show who assessed and prescribed, who administered, the product and batch used, the consent taken, and the aftercare given.
That last point matters more than it first appears. If a question ever arises, whether from a regulator, an insurer or a patient, your contemporaneous record of who prescribed, who administered and which product and batch were used is your evidence that the treatment was carried out properly.
Whoever prescribes and whoever administers, the responsibility to keep a clear record of the treatments you carry out sits with you. That is one of the reasons I built Aesthetics Logbook: a simple app for logging your treatments and CPD as you work, with space to capture reflections and feedback against each entry too. It is designed around how aesthetic clinicians actually practise, and avoids storing direct patient identifiers to support data-minimisation. Your case numbers, activity and evidence build quietly in the background, ready for appraisal, revalidation or an insurer's query, rather than being reconstructed from memory. If that would make your next review easier, you can find it at aestheticslogbook.com.
If you are a patient
If you are considering treatment, a few simple questions protect you:
Who will prescribe my treatment, and will they assess me in person first?
Is the person injecting me trained, insured and able to manage complications?
If I have filler, how quickly could a complication be treated, including access to hyaluronidase?
What product is being used, and will it be recorded?
A good practitioner will welcome these questions. Reluctance to answer them is itself a useful warning sign.
This guide is for general information and reflects the position in England at the time of writing. The law and regulation of non-surgical cosmetic procedures is developing, and the detail can differ across the UK. Practitioners should check the current guidance from their own regulator and indemnity provider, and patients should raise any questions directly with their practitioner.
